CG Oncology, Inc. (CGON) Institutional Ownership
As of the Mar 31, 2026 13F filing cycle, 173 institutions reported holding CG Oncology, Inc. (CGON), together worth $4.78B. Compared to Dec 31, 2025: 84 increased their position, 0 opened a new one, 63 trimmed, and 0 fully exited, a net addition of 6.29M shares. The 10 largest institutional holders control +61% of all institutionally-held shares. Notable names on the list include MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, Point72 Asset Management, L.P..
As of the Mar 31, 2026 13F filing cycle, compared to Dec 31, 2025. Institutions have up to 45 days after quarter-end to file, so this can lag real-time positioning.
The largest position increases, new positions, decreases, and confirmed exits this cycle. Percent-change lists below require at least a $1M prior-quarter position, so a fund going from a handful of shares to a few thousand does not crowd out real, sized moves.
A small, non-exhaustive list of well-known funds and passive index giants we checked for by name, not a comprehensive classification of every institution on record.
These alone represent about +14% of total institutional value on record, a rough floor for index-driven (not conviction-driven) ownership.
"Since prior quarter" return uses each holder's prior-quarter value divided by prior-quarter shares as a rough implied entry price, not their real cost basis, which is not disclosed in 13F filings.
| Institution | Status | Shares | Value | Change | Since Prior Qtr |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | Increased | 6.98M | $472.73M | +247.14% | +79.0% |
| Decheng Capital LLC | Unchanged | 6.37M | $431.23M | 0.00% | +79.0% |
| WELLINGTON MANAGEMENT GROUP LLP | Decreased | 5.37M | $363.52M | -10.48% | +79.0% |
| BlackRock, Inc. | Increased | 5.06M | $342.74M | +4.56% | +79.0% |
| VANGUARD GROUP INC | Unclear (Last Known) | 6.54M | $271.52M | — | +79.0% |
| FMR LLC | Decreased | 3.76M | $254.80M | -12.41% | +79.0% |
| TCG Crossover Management, LLC | Unchanged | 3.67M | $248.40M | 0.00% | +79.0% |
| Caption Management, LLC | Increased | 2.76M | $186.72M | +110.72% | +79.0% |
| STATE STREET CORP | Decreased | 2.65M | $179.15M | -11.67% | +79.0% |
| Foresite Capital Management VI LLC | Unchanged | 2.22M | $150.35M | 0.00% | +79.0% |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1.60M | $108.10M | +5.65% | +79.0% |
| FRANKLIN RESOURCES INC | Decreased | 1.51M | $101.99M | -3.49% | +79.0% |
| BANK OF AMERICA CORP /DE/ | Increased | 1.45M | $98.09M | +21.79% | +79.0% |
| DV Trading LLC | Unchanged | 1.44M | $97.42M | 0.00% | +79.0% |
| UBS Group AG | Decreased | 1.31M | $88.79M | -31.80% | +79.0% |
| Avidity Partners Management LP | Decreased | 1.29M | $87.24M | -12.48% | +79.0% |
| GOLDMAN SACHS GROUP INC | Decreased | 1.16M | $78.46M | -12.48% | +79.0% |
| ACORN CAPITAL ADVISORS, LLC | Decreased | 1.13M | $76.58M | -0.09% | +79.0% |
| EcoR1 Capital, LLC | Increased | 1.10M | $74.58M | +3.49% | +79.0% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | Decreased | 1.06M | $72.08M | -2.38% | +79.0% |
How many institutions hold CGON stock?
173 institutions reported a position in CG Oncology, Inc. as of the Mar 31, 2026 13F filing cycle, worth a combined $4.78B.
Are institutions buying or selling CGON?
Comparing Mar 31, 2026 to Dec 31, 2025: 84 institutions increased their position and 0 opened new ones, while 63 decreased and 0 fully exited. Net share change: 6.29M.
How concentrated is institutional ownership of CGON?
The top 10 institutional holders control +61% of all shares held by institutions on record, a fairly concentrated group of holders.
How current is this institutional ownership data?
This reflects the Mar 31, 2026 13F filing cycle. Institutional investors have up to 45 days after quarter-end to file, so this data can lag real-time positioning by 1-3 months, and only U.S.-registered institutional managers above the SEC's reporting threshold are required to file at all.